Showing results (1641-1650 of 1,880) with videos related to

Sort By:
Pageof 188
Immunotherapy|December 20, 2014
Candidin and trichophytin stimulate the production of Th1 and regulatory cytokines by peripheral blood mononuclear cells: implication for their use as adjuvants in immunotherapyAna Lúcia Moreno Amor, Leonardo Nascimento Santos, Alana Alcântara Galvão, et al.
Immunotherapy|December 20, 2014
Past, present and future targets for immunotherapy in ovarian cancerCarlton L Schwab, Diana P English, Dana M Roque, et al.
Immunotherapy|November 28, 2014
Five-grass pollen immunotherapy tablet: an update on the latest findings from clinical trials: an interview with Olivier de BeaumontOlivier de Beaumont, Jonathan Wilkinson
Immunotherapy|November 28, 2014
Targeting the alternatively spliced soluble isoform of CTLA-4: prospects for immunotherapy?Frank J Ward, Lekh N Dahal, Rahul C Khanolkar, et al.
Immunotherapy|November 28, 2014
Anti-TNF therapeutics for the treatment of sarcoidosisHeleen A Crommelin, Adriane D M Vorselaars, Coline H M van Moorsel, et al.
Immunotherapy|November 28, 2014
Physical and immunological aspects of exercise in chronic diseasesVasso Apostolopoulos, Erika Borkoles, Remco Polman, et al.
Immunotherapy|October 15, 2014
Carboplatin hypersensitivity: evaluation and successful desensitization protocolIlan Bruchim, Arnon Goldberg, Ami Fishman, et al.
Immunotherapy|November 5, 2020
Immune checkpoint inhibitor use, multimorbidity and healthcare expenditures among older adults with late-stage melanomaPragya Rai, Chan Shen, Joanna Kolodney, et al.
Immunotherapy|September 9, 2020
Osteonecrosis of the jaw induced by treatment with anti-PD-1 immunotherapy: a case reportXerxes Pundole, Amy Little Jones, Michael T Tetzlaff, et al.
Immunotherapy|September 4, 2020
Cost-effectiveness of pembrolizumab plus axitinib as first-line therapy for advanced renal cell carcinomaJiaxin Zhu, Tiantian Zhang, Ning Wan, et al.
Pageof 188